Related Experiment Video
Updated: Jun 9, 2026

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
A comprehensive review on the role of plant-derived bioactive metabolites driving ROS-mediated apoptosis in cancer
Canivizhi Vidjeyamannane1, Alan Joy1, Kishore Prakash1
1Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603 203, India.
Abstract:
Reactive Oxygen Species (ROS) are essential in inducing cancer cell death through the promotion of oxidative stress, DNA damage, and the disturbance of cellular homeostasis. Natural bioactive chemicals sourced from plants and other natural products are significant for their capacity to selectively regulate ROS levels and cause apoptosis in cancer cells while sparing normal cells. The study gives a thorough summary of the molecular mechanisms of ROS-induced apoptosis, including mitochondrial damage, pro-apoptotic pathway activation, and inhibition of anti-apoptotic proteins. The review focuses on several natural bioactive molecules, such as polyphenols, flavonoids, alkaloids, and terpenoids that have anticancer activity through ROS induction. The potential therapeutic application of the compounds in increasing the effectiveness of standard cancer therapies and reducing drug resistance is likewise discussed. In addition, the review discusses the challenge of clinical translation of these bioactive compounds with respect to bioavailability, stability, and site-specific delivery. In conclusion, this review highlights the promising potential of ROS-modulating bioactive compounds as a new therapeutic strategy for cancer treatment, with insights into their mechanistic action and therapeutic implications.
Insights
Natural compounds can selectively induce cancer cell death by regulating Reactive Oxygen Species (ROS). This review explores their mechanisms, therapeutic potential, and challenges for cancer treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Reactive Oxygen Species (ROS) play a dual role in cancer, inducing cell death via oxidative stress and DNA damage.
- Natural bioactive compounds offer selective ROS modulation for cancer therapy, targeting cancer cells while sparing normal cells.
Purpose of the Study:
- To summarize the molecular mechanisms of ROS-induced apoptosis in cancer.
- To review natural bioactive molecules with anticancer activity via ROS induction.
- To discuss therapeutic applications and clinical translation challenges of these compounds.
Main Methods:
- Literature review of studies on ROS, apoptosis, and natural bioactive compounds.
- Analysis of molecular pathways involved in ROS-induced cancer cell death.
- Evaluation of the therapeutic potential and limitations of natural compounds.
Main Results:
- Natural compounds like polyphenols, flavonoids, alkaloids, and terpenoids induce apoptosis through mitochondrial damage and pathway modulation.
- These compounds show potential in enhancing standard cancer therapies and overcoming drug resistance.
- Clinical translation is challenged by issues of bioavailability, stability, and targeted delivery.
Conclusions:
- ROS-modulating natural compounds represent a promising therapeutic strategy for cancer.
- Understanding their mechanisms is key to developing effective cancer treatments.
- Further research is needed to address clinical translation challenges for these bioactive compounds.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Survival Analysis